Literature DB >> 6812730

Use of invasive neuroradiological investigations in patients with normal computerised tomography.

G L Tatler, I F Moseley.   

Abstract

A review of the results of neuroradiological investigation of patients in whom computed tomography had shown no intracranial abnormality showed that the use of invasive studies, particularly pneumoencephalography, has declined since installation of a computed tomography scanner, and indications for such studies have become firmer. Diagnostic yield from invasive procedures in patients presenting with epilepsy, dementia, headache (including facial pain), or loss of consciousness is negligible.

Entities:  

Mesh:

Year:  1982        PMID: 6812730      PMCID: PMC1500307          DOI: 10.1136/bmj.285.6347.1026

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  4 in total

1.  The use of computed axial tomography (CAT) for the diagnosis and management of intracranial angiomas.

Authors:  B E Kendall; L E Claveria
Journal:  Neuroradiology       Date:  1976       Impact factor: 2.804

2.  Comparison of E.M.I. and radioisotope imaging in neurological disease.

Authors:  G H Du Boulay; J Marshall
Journal:  Lancet       Date:  1975-12-27       Impact factor: 79.321

3.  A clinical study of the EMI scanner: implications for provision of neuroradiological services.

Authors:  J R Bartlett; G Neil-Dwyer
Journal:  Br Med J       Date:  1978-09-16

4.  Some limitations of computed tomography in the diagnosis of neurological diseases.

Authors:  K R Davis; J M Taveras; G H Roberson; R H Ackerman
Journal:  AJR Am J Roentgenol       Date:  1976-07       Impact factor: 3.959

  4 in total
  2 in total

1.  Long term effects of the introduction of noninvasive investigations in neuroradiology. Part 1: Overall trends.

Authors:  I F Moseley
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

Review 2.  Imaging the adult brain.

Authors:  I Moseley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.